Literature DB >> 12566116

Increased expression of cardiac angiotensin II type 1 (AT(1)) receptors decreases myocardial microvessel density after experimental myocardial infarction.

Rudolf A de Boer1, Yigal M Pinto, Albert J H Suurmeijer, Saraswati Pokharel, Egbert Scholtens, Michael Humler, Juan M Saavedra, Frans Boomsma, Wiek H van Gilst, Dirk J van Veldhuisen.   

Abstract

OBJECTIVE: To study the effects of increased levels of myocardial angiotensin II type 1 (AT(1)) receptor on microvascular growth following myocardial infarction (MI).
METHODS: MI was created in transgenic rats (TGR) with a cardioselective overexpression of the AT(1) receptor. We used Sprague-Dawley (SD) rats as controls. Some of the rats were treated with the selective AT(1) receptor blocker losartan (Los). Rats were sacrificed after 3 weeks.
RESULTS: MI caused left ventricular (LV) hypertrophy and LV dysfunction in both SD and TGR, which was prevented by AT(1) receptor blockade. Furthermore, MI decreased microvessel density in the non-infarcted myocardium (SD MI: 1653+/-37/mm(2), P<0.01 vs. sham-operated controls), however, microvessel density decreased significantly more in TGR with MI (1298+/-33/mm(2), P<0.01 vs. SD MI). AT(1) receptor blockade restored microvessel density (SD MI Los: 2046+/-195/mm(2); TGR MI Los: 1742+/-47/mm(2); P<0.01 vs. untreated). The differences in microvessel density were still present after correction for LV hypertrophy. The increase in microvessel density after AT(1) receptor blockade was not accompanied by increased myocardial vascular endothelial growth factor (VEGF) levels. Microvessel density correlated with parameters of myocardial stretch, such as LV end-diastolic pressure (-0.681, P<0.001) and N-ANP (-0.424, P=0.01).
CONCLUSIONS: Microvessel density after MI is decreased when the AT(1) receptor is overexpressed, and this is amenable to AT(1) receptor blockade. This suggests that efficacy of AT(1) receptor blockers post-MI may not only be due to attenuation of LV remodeling, but also to a stimulatory effect on angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12566116     DOI: 10.1016/s0008-6363(02)00704-6

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  13 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

2.  Divergent effects of losartan and metoprolol on cardiac remodeling, c-kit+ cells, proliferation and apoptosis in the left ventricle after myocardial infarction.

Authors:  Raisa Serpi; Anna-Maria Tolonen; Olli Tenhunen; Oskari Pieviläinen; Anna-Maria Kubin; Tommi Vaskivuo; Ylermi Soini; Risto Kerkelä; Hanna Leskinen; Heikki Ruskoaho
Journal:  Clin Transl Sci       Date:  2009-12       Impact factor: 4.689

3.  rAAV-mediated angiogenin gene transfer induces angiogenesis and modifies left ventricular remodeling in rats with myocardial infarction.

Authors:  Xiao-Yan Zhao; Shen-Jiang Hu; Jiang Li; Yun Mou; Chi-Fung Chan; Juan Jin; Jian Sun; Zhao-Hui Zhu
Journal:  J Mol Med (Berl)       Date:  2006-09-06       Impact factor: 4.599

4.  Capillaries as a Therapeutic Target for Heart Failure.

Authors:  Yohko Yoshida; Ippei Shimizu; Tohru Minamino
Journal:  J Atheroscler Thromb       Date:  2022-04-01       Impact factor: 4.394

5.  Hypercholesterolaemia exacerbates ventricular remodelling after myocardial infarction in the rat: role of angiotensin II type 1 receptors.

Authors:  M Maczewski; J Maczewska; M Duda
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

Review 6.  Intracardiac renin-angiotensin system and myocardial repair/remodeling following infarction.

Authors:  Yao Sun
Journal:  J Mol Cell Cardiol       Date:  2009-08-12       Impact factor: 5.000

Review 7.  Factors affecting the development of adverse drug reactions (Review article).

Authors:  Muaed Jamal Alomar
Journal:  Saudi Pharm J       Date:  2013-02-24       Impact factor: 4.330

8.  Cytokine combination therapy with erythropoietin and granulocyte colony stimulating factor in a porcine model of acute myocardial infarction.

Authors:  Franca S Angeli; Nicolas Amabile; Mia Shapiro; Rachel Mirsky; Lauren Bartlett; Yan Zhang; Renu Virmani; Kanu Chatterjee; Andrew Boyle; William Grossman; Yerem Yeghiazarians
Journal:  Cardiovasc Drugs Ther       Date:  2010-12       Impact factor: 3.727

9.  Regulation of the (pro)renin-renin receptor in cardiac remodelling.

Authors:  Hasan Mahmud; Herman H W Silljé; Megan V Cannon; Wiek H van Gilst; Rudolf A de Boer
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

10.  Impact of comorbidity on adverse drug reaction profile in a cohort of patients treated with Artemisinin combination therapies for uncomplicated malaria in Nigeria.

Authors:  Peter U Bassi; Adeline I Osakwe; Comfort K Ogar; Cassandra Elagbaje; Biyaya B Nwankwo; Sulayman T Balogun; Godwin N Ntadom; Ambrose O Isah
Journal:  Pharmacol Res Perspect       Date:  2017-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.